EM2007F "Chronic Lymphocytic Leukemia – from “Chemo”-therapy to “Chronic” therapy" (IM GR-072420)
The presentation aims to provide an update on the recent advances in the management of patients with CLL, the most prevalent leukemia in the western hemisphere. We will specifically focus on how these advances impact the multi-disciplinary management of patients with CLL, especially with regards to various non-oncologic medical specialties. Given the improved survival and changes in treatment paradigms we will discuss new data and suggest management options to provide better comprehensive care to our patients.
Target Audience
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
Learning Objectives
At the conclusion of this activity, the participant should be able to:
- Appreciate the heterogeneity of CLL.
- Describe the latest developments in the management of CLL.
- Identify issues related to the management of our patients and recommend appropriate management.
Farrukh Awan, M.D.
Associate Professor, Department of Internal Medicine
Division of Hematology & Oncology
Director of Lymphoid Malignancies Program
Available Credit
- 1.00 AMA
Price
Required Hardware/software
Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome